🇺🇸 FDA
Pipeline program

Ropivacaine injection

HSC20190878H

Phase 2 small_molecule active

Quick answer

Ropivacaine injection for Stress Disorders, Post-Traumatic is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Stress Disorders, Post-Traumatic
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials